Technology · Biotechnology R&D expenditure

Biotechnology R&D expenditure in Norway in 2026

Norway's expenditure on biotechnology research and development stands at 200 M $ in 2026. This reflects the structure of the Norwegian economy, dominated by oil, gas, and seafood, where biotech has not yet become a priority for public funding. Unlike countries with strong pharmaceutical clusters, Norwegian R&D focuses on marine biotechnology and salmon genomics. The country ranks 19 out of 197 in R&D spending.

Data for 2026 · unit: $
Position

Norway world ranking

#19 / 197

Country position on the scale from last to first place for this indicator.

NO
#19
#197#1
Trend

Change over time

Change in indicator over the available period.

50 M
1990
100 M
2000
200 M
2010
150 M
2020
180 M
2025
200 M
2026

Values — $

Related questions

People also search for

Other pages of the reference by this indicator.

Summary

Frequently asked questions

Biotechnology R&D expenditure in Norway — how much?
Based on 2026 data — 200 M $. This is rank #19 out of 197 countries.
What is Norway's rank by Biotechnology R&D expenditure?
Norway ranks #19 out of 197 countries in the world ranking by «Biotechnology R&D expenditure».
How has Biotechnology R&D expenditure changed in Norway?
Over the available period the indicator changed from 50 M to 200 M $.